Results 71 to 80 of about 1,882,529 (345)

Gluten sensitivity and neurological manifestations

open access: yesJournal of Biological Research, 2015
The authors report on six cases of gluten-sensitivity, also defined non-celiac gluten sensitivity, characterized by abdominal features (diarrhea, bloating, pain), genetic positivity for predisposition to celiac disease (DQB1* 02 in all cases; DQA1*05 in ...
Agostino Berio   +3 more
doaj   +1 more source

Neurological manifestations of COVID-19 in patients: from path physiology to therapy

open access: yes, 2021
Coronavirus is a family of ARN positive single-stranded belonging to the family of Coronaviridae. There are several families of coronavirus that transmit more or less serious diseases.
Benedí González, Juana María   +3 more
core   +1 more source

Neurologic manifestations of COVID 19 in children: Prospective study in a single center

open access: yesAnnals of Indian Academy of Neurology, 2021
Background: The data related to the neurologic manifestations of coronavirus disease 2019 (COVID-19) in children are limited. The frequency of the neurologic manifestations and the risk factors in the development of these symptoms are not clear ...
Esra Gürkas   +6 more
doaj   +1 more source

The neurological manifestations of COVID-19: a review article

open access: yesNeurological Sciences, 2020
Results Various neurological manifestations have been reported in the literature associated with COVID-19, which in the current study are classified into Central Nervous System (CNS) related manifestations including headache, dizziness, impaired ...
H. Niazkar   +3 more
semanticscholar   +1 more source

Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German society of neurology

open access: yesNeurological Research and Practice, 2022
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to COVID-19 (COrona VIrus Disease-2019). SARS-CoV-2 acute infection may be associated with an increased incidence of neurological manifestations such as encephalopathy ...
C. Franke, P. Berlit, H. Prüss
semanticscholar   +1 more source

Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain

open access: yesFrontiers in Medicine, 2020
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), has caused a global pandemic in only 3 months.
Zhengqian Li   +9 more
semanticscholar   +1 more source

Sarcoidosis of the hypothalamus and pituitary stalk [PDF]

open access: yes, 1992
We report a rare case of sarcoidosis of the hypothalamic and suprasellar region, with clinical course and the magnetic resonance imaging follow ...
Stemmler, J.   +3 more
core   +1 more source

Factors Associated With Neurological Manifestations in Patients With COVID-19

open access: yes, 2022
Background: The coronavirus disease 2019 (COVID-19) is the most terrible pandemic of a respiratory disease that we had in the past century. Most existing studies explore different manifestations in COVID-19. Few recent studies have described neurological
Mohammad Mahdi Niksima   +11 more
core   +1 more source

Neurological Involvement in Pediatric Patients with Acute Leukemia: A Retrospective Cohort

open access: yesChildren, 2022
Acute leukemia (AL) is an important cause of morbidity and mortality in children, and neurological manifestations (NM) are frequent. The objective of this study was to analyze neurological manifestations in children with acute leukemia from cases ...
Diana Alejandra Cruz-Chávez   +16 more
doaj   +1 more source

Therapeutic Apheresis for Intravenous Methylprednisolone‐Refractory Neuromyelitis Optica Spectrum Disorder: Clinical and Radiological Outcomes in a Single‐Center Case Series

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system. High‐dose intravenous methylprednisolone (IVMP) is the standard first‐line therapy for acute attacks, although some patients remain refractory.
Wataru Horiguchi   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy